Jefferies Group LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$3,156,026
+541.7%
46,344
+226.4%
0.03%
+766.7%
Q1 2022$491,819
-74.3%
14,198
-81.1%
0.00%
-78.6%
Q3 2021$1,911,000
-1.7%
75,000
+35.1%
0.01%
+16.7%
Q2 2021$1,943,400
-61.8%
55,494
-39.9%
0.01%
-78.9%
Q3 2020$5,092,000
-74.1%
92,351
-70.4%
0.06%
-75.4%
Q2 2020$19,671,000
+88.1%
311,587
+52.2%
0.23%
+98.3%
Q1 2020$10,460,000
+704.0%
204,738
+1150.9%
0.12%
+1070.0%
Q4 2019$1,301,000
-77.1%
16,367
-86.0%
0.01%
-77.3%
Q3 2019$5,676,000
-38.4%
117,000
-33.2%
0.04%
-34.3%
Q2 2019$9,213,000
+210.8%
175,160
+212.8%
0.07%
+179.2%
Q1 2019$2,964,000
-37.3%
56,000
-51.3%
0.02%
-36.8%
Q4 2018$4,724,000
-54.6%
115,057
-58.0%
0.04%
-43.3%
Q3 2018$10,412,000
-17.2%
274,007
-1.5%
0.07%
-4.3%
Q2 2018$12,570,000
+2082.3%
278,100
+1012.4%
0.07%
+2233.3%
Q3 2016$576,000
+21.0%
25,000
-16.7%
0.00%0.0%
Q1 2016$476,00030,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders